skip to content
Detailed Quote
5i Report
Rating
B+

Review of WELL Health Technologies

AUG 30, 2022 - We believe the company’s acquisition model has worked well for the company and has positioned itself well in both Canada and the US. We would consider WELL to be our top pick for health care technology in Canada and maintain our rating of ‘B+’.

Download Report
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Good evening,

I currently own VMD, VHI, LLY, and WELL. I'm considering a consolidation down to three of the four stocks. For a five-year hold, how might you rank these in terms of overall growth potential and risk? Thanks, Brad
Read Answer Asked by Bradley on April 24, 2024
Q: Hello, Would you have 4 top picks in either of these sectors (industrials, consumer staples, consumer discretionary or health care). I am looking for large caps trading on the TSX with good long term potential. Thank you.
Read Answer Asked by Pierre on April 23, 2024
Q: Hi,
I have been currently holding these for awhile and have done well on them, other than maybe WELL, which has been lagging a bit lately. Here are my allocations: WELL (1.7%), SLF (2%), GSY (3.5%) and NVDA (3.8%).

Recently in the last few months, I trimmed some NVDA and bought some VRT (1%) and SMCI (1%). For a growth investor, how would you rank these 3 stocks going forward? Would you continue to trim and buy these smaller cap higher growth names. With the run that they've had, I've been a little more cautious of a slowdown.

Also with these other names I'm holding, I'm contemplating trimming or completely switching to higher growth and better quality names with better runway for growth. What are your thoughts? Trim, add or switch? For example, does it make sense to trim a 3.0% position into two names that are only 1.5%? I'm against diworsification. Thank you!

1. WELL to VHI
2. SLF to IFC
3. GSY to PRL
Read Answer Asked by Keith on April 18, 2024
Insiders
Share Information
News and Media